Diaceutics delivers 25% first half revenue growth as platform adoption accelerates
-First-half revenue up 25%-Increased adoption of platform representing 76% of revenues-Improved quality and visibility of earningsDiagnostic platform provider for precision medicines Diaceutics (DXRX:AIM) delivered 25% organic...
27 September 2022